Subscribe to our Newsletters !!
Climate change is very disruptive to the Amazon ra
Industries and scientific fields use conductivity
Insects that are given more attention and reverenc
Alembic Pharmaceuticals Limited appoints Mr. Manis
The importance of comparing the treatment of asthm
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of The Magazine
Delhi, 21st November 2022: Continuing the winning streak of CPhI & P-MEC India, Informa Markets, the leading international B2B events group is once again back with its 15th edition in an evolved hybrid format to be held from 29th November to 1st December 2022 at the India Expo Centre, Greater Noida, Delhi – NCR. Embracing modernization CPhI & P-MEC India create platforms to showcase modern technologies critical in facilitating advancement in India’s pharma machinery, technology, and ingredients industries. Indian pharmaceutical industry is set to grow at a 12% CAGR and reach $130billion (INR 10.5 lakh crores) by 2030. The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees. To stimulate the anticipated growth of the industry, a pre-connect congress will take place on 28th November 2022 at Crowne Plaza, Mayur Vihar, New Delhi.
The expo will yet again be a marketplace to bridge the ecosystem with knowledge, technologies and market opportunities. CPhI & P-MEC India are expected to witness over 1500 exhibitors, more than 40,000 visitors and representation from over 80 + Countries over the 3-days. It gives direct access highly targeted senior pharma executives, buyers, procurement managers, contract manufacturers, hospital administration, and many more along with National and State Regulatory Boards, and Policymakers to congregate and conduct business, arrive at solution-driven innovations to counteract economic uncertainties and domestic trade in India.
CPhI and P-MEC India is a gateway to discover various opportunities and build successful business relationships with hundreds of participating companies and industry leaders. Some of the key exhibitors include Ansell, Windlas, Namau Chem, Invision Pharma Ltd., Embellish, Stivaph Healthcare private ltd., DRL, Molkem, Bioextract, RIVPRA and many more. This year again the expo garnered extensive support from associations like Pharmexcil, CIPI, IDMA, ASPA, IPA, IPEC, and KDPMA reaffirming it as industry’s most promising show.
Emphasizing on this year’s CPhI & P-MEC India Expo, Mr. Yogesh Mudras, Managing Director, Informa Markets in India said, “The Indian pharma Market is rising at an annual growth rate of 15%, which is twice the world market growth rate. To further accelerate the growth of this industry, the government has approved incentives to the tune of almost INR 22,000 crores and 100% FDI, under the automatic route for greenfield pharmaceuticals.
Over the last 15 years, our show CPhI and P-MEC India has demonstrated excellence in supporting the industry and growing along with it by curating highly effective platforms for showcasing technology solutions, knowledge sharing, networking, and advocacy in the past and will continue to act as a catalyst to ‘Make in India ‘movement and provide an impetus to Indian economy. The expo will surely provide a huge platform to establish and enhance business by meeting active suppliers looking for collaboration with the Indian Pharma and Healthcare market. Every edition of CPhI and P-MEC India has set a successful milestone for its esteemed visitors and this year too, we will raise the bar to give a significant boost to this industry,” he added.
The India Pharma Week, of which the expo is a prominent part, fill further provide and encourage the halo around the pharma sector. The marquee show starts with the pre-connect Congress that will include Mr. Amit Saluja, Senior Director and Center Head – Gandhinagar CoE NASSCOM CoE, Gandhinagar, Dr. Sanjit Singh Lamba CEO Biocuris, Mr.Suresh Pattathil President – OPPI, General Manager, AbbVie India, Mr Vickram Srivastava Head Global Supply chain Sun Pharmaceutical Industries Ltd amongst others. The key topics of the panel discussions would include ‘Disrupting the pharmaceutical industry in the age of rapid technological growth’, ‘Paving the pathway for innovation in pharma R&D’,’ Adaptive, responsive, and flexible supply chain to fuel pharma growth’ and ‘Changing global dynamics & opportunities for enhancing India’s pharma exports.’
1.Grand 15th edition of CPhI & P-MEC India Expo to be held from 29th November-1st December 2022, at the India Expo Centre, Greater Noida, Delhi-NCR.2.The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees.3.The shows will bring together 1000+ suppliers showcasing 5000+ products across 100,000+ sq m of exhibition space.
1.Grand 15th edition of CPhI & P-MEC India Expo to be held from 29th November-1st December 2022, at the India Expo Centre, Greater Noida, Delhi-NCR.
2.The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees.
3.The shows will bring together 1000+ suppliers showcasing 5000+ products across 100,000+ sq m of exhibition space.
Alongside the display of the latest technologies, of CPhI & P-MEC India, The India Pharma Week which will include 9th Annual India pharma awards and CEO Roundtable on Day 1 will bring all key stakeholders in the pharmaceutical industry on a single platform to discuss, deliberate, and shares their thoughts on achieving the next phase of growth in pharma. Day 2 will see Women in Pharma Roundtable which an initiative is aimed at acknowledging and celebrating the significant and continued contribution of women to the pharmaceutical industry in a closed-door roundtable discussion.
About the CPhI & P-MEC expo:
Originating from CPhI Worldwide – CPhI India has become South Asia’s leading Pharma meeting place covering every step of the supply chain from drug discovery to finished dosage, encompassing CROs, CMOs, and manufacturers of API, Generics, Excipients and Drug formulation, Fine chemicals, Biosimilars, Finished Formulations, Lab chemicals, and Biotechnology.
P-MEC, on the other hand, includes manufacturers of Pharma Machinery and Equipment, Analytical Equipment, Automation & Robotics, Packaging Equipment & Supplies, Plant / Facility Equipment, Automation & Controls, Processing Equipment, RFID, Tableting / Capsule fillers, Cleanroom equipment, Filling equipment and Laboratory products.
About Informa Markets
Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com
About Informa Markets and our business in India
Informa Markets is owned by Informa PLC, a leading B2B information services group and the largest B2B Events organiser in the world. Informa Markets in India (formerly UBM India) is India’s leading exhibition organizer, dedicated to help specialist markets and customer communities, domestically and around the world to trade, innovate and grow through exhibitions, digital content & services, and conferences & seminars. Every year, we host over 25 large scale exhibitions, 40 conferences, along with industry awards and trainings across the country; thereby enabling trade across multiple industry verticals. In India, Informa Markets has offices in Mumbai and New Delhi.
